The Congressional Budget Office (CBO) estimates that re-importing prescription drugs from Canada will save virtually nothing.

Many will find this counter intuitive, especially in light of all the misinformation and political rhetoric – and the uneven reporting on the issue. As with so many of the “Taste Great vs. Less Filling” debates in health policy, perceptions are overly simplistic and out of touch with economic reality.

CBO – an independent, skilled, and studiously nonpartisan arm of Congress – examined the real-world economic dynamics. Read the CBO report here (PDF). It’s a quick, eye-opening read.